{"nct_id":"NCT04509622","title":"A Study of Oral Venetoclax Tablet in Combination With Subcutaneous Low-Dose Cytarabine (LDAC) Injection to Assess Adverse Events in Adult Japanese Participants With Acute Myeloid Leukemia (AML)","status":"COMPLETED","status_verified_date":"2022-05","start_date":"2020-10-05","start_date_type":"ACTUAL","primary_completion_date":"2021-04-15","primary_completion_date_type":"ACTUAL","completion_date":"2021-04-15","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ABBV"]}